Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Medicinal Chemistry|July 1, 1988
Polycyclic aryl- and heteroarylpiperazinyl imides as 5-HT1A receptor ligands and potential anxiolytic agents: synthesis and structure-activity relationship studiesM Abou-Gharbia, U R Patel, M B Webb, et al.Academic Medicine : Journal of the Association of American Medical Colleges|September 25, 2014
A first step toward understanding best practices in leadership training in undergraduate medical education: a systematic reviewAllison M B Webb, Nicholas E Tsipis, Taylor R McClellan, et al.Academic Medicine : Journal of the Association of American Medical Colleges|April 5, 2019
A Timely Problem: Parental Leave During Medical TrainingAllison M B Webb, Brittany N Hasty, Kathryn M Andolsek, et al.Journal of Medicinal Chemistry|June 4, 1999
New generation dopaminergic agents. 6. Structure-activity relationship studies of a series of 4-(aminoethoxy)indole and 4-(aminoethoxy)indolone derivatives based on the newly discovered 3-hydroxyphenoxyethylamine D2 templateR E Mewshaw, M B Webb, K L Marquis, et al.The European Respiratory Journal|September 4, 1998
Development and validation of a screening test for 12 common mutations of the cystic fibrosis CFTR geneN H Robertson, S L Weston, S J Kelly, et al.Journal of Medicinal Chemistry|December 22, 1999
Synthesis and SAR of adatanserin: novel adamantyl aryl- and heteroarylpiperazines with dual serotonin 5-HT(1A) and 5-HT(2) activity as potential anxiolytic and antidepressant agentsM A Abou-Gharbia, W E Childers, H Fletcher, et al.Bioorganic & Medicinal Chemistry Letters|January 1, 1999
New generation dopaminergic agents. 2. Discovery of 3-OH-phenoxyethylamine and 3-OH-N1-phenylpiperazine dopaminergic templatesR E Mewshaw, M Husbands, E S Gildersleeve, et al.Journal of Medicinal Chemistry|January 22, 1998
New generation dopaminergic agents. 1. Discovery of a novel scaffold which embraces the D2 agonist pharmacophore. Structure-activity relationships of a series of 2-(aminomethyl)chromansR E Mewshaw, J Kavanagh, G Stack, et al.Pageof 3